Resumen

LAMBEA-GIL, Alvaro et al. Merkel Cell Carcinoma In A Patient With Multiple Sclerosis Treated With Fingolimod. Rev Ecuat Neurol [online]. 2021, vol.30, n.1, pp.197-199. ISSN 2631-2581.  https://doi.org/10.46997/revecuatneurol30100197.

Fingolimod is a disease-modifying therapy widely used in Relapsing-Remittent Multiple Sclerosis. It blocks the capacity of lymphocytes to leave the lymph nodes, causing lymphopenia. This increases the risk of infections, but also non-melanocytic skin tumours. We report a case of Merkel cell carcinoma in a patient treated with fingolimod and a review of the literature, which helps to understand the relation between immunosuppression, opportunistic infections and cancer.

Palabras clave : Cancer; Merkel Cell Carcinoma; Fingolimod; Immunosuppression; Adverse effect; Multiple Sclerosis.

        · resumen en Español     · texto en Español     · Español ( pdf )